Ticker
LUNGCompany Name
PULMONX CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 147.19M | $ 18.07M | 12.27% |
3/31/2025 | $ 150.74M | $ 18.18M | 12.06% |
12/31/2024 | $ 162.85M | $ 18.6M | 11.42% |
9/30/2024 | $ 167.4M | $ 19.23M | 11.48% |
6/30/2024 | $ 172.63M | $ 19.28M | 11.17% |
3/31/2024 | $ 164.58M | $ 19.75M | 12% |
12/31/2023 | $ 177.78M | $ 19.32M | 10.87% |
9/30/2023 | $ 185.02M | $ 19.58M | 10.58% |
6/30/2023 | $ 193.11M | $ 20.07M | 10.39% |
3/31/2023 | $ 201.27M | $ 20.36M | 10.12% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for PULMONX CORP is calculated as follows: Inventory [ $ 9.29M ] / Assets [ $ 71.24M ]
(=) Inv. to Assets [ 13.04% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.09% |
median | 0% |
std | 11.11% |